Clinical Trial Detail

NCT ID NCT02072486
Title Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Roswell Park Cancer Institute
Indications

hepatocellular carcinoma

Therapies

Sorafenib

Age Groups: adult

No variant requirements are available.